WO2001081581A3 - Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire - Google Patents
Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire Download PDFInfo
- Publication number
- WO2001081581A3 WO2001081581A3 PCT/US2001/012865 US0112865W WO0181581A3 WO 2001081581 A3 WO2001081581 A3 WO 2001081581A3 US 0112865 W US0112865 W US 0112865W WO 0181581 A3 WO0181581 A3 WO 0181581A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- diagnosis
- therapy
- methods
- acne vulgaris
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 3
- 206010000496 acne Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 241000186427 Cutibacterium acnes Species 0.000 abstract 3
- 229940055019 propionibacterium acne Drugs 0.000 abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01928693A EP1278854A2 (fr) | 2000-04-21 | 2001-04-20 | Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire |
AU2001255524A AU2001255524A1 (en) | 2000-04-21 | 2001-04-20 | Compositions and methods for the therapy and diagnosis of acne vulgaris |
CA002407352A CA2407352A1 (fr) | 2000-04-21 | 2001-04-20 | Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire |
JP2001578652A JP2004520803A (ja) | 2000-04-21 | 2001-04-20 | 尋常性挫瘡の治療および診断のための組成物および方法 |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19904700P | 2000-04-21 | 2000-04-21 | |
US60/199,047 | 2000-04-21 | ||
US20884100P | 2000-06-02 | 2000-06-02 | |
US60/208,841 | 2000-06-02 | ||
US21674700P | 2000-07-07 | 2000-07-07 | |
US60/216,747 | 2000-07-07 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001081581A2 WO2001081581A2 (fr) | 2001-11-01 |
WO2001081581A3 true WO2001081581A3 (fr) | 2002-03-14 |
WO2001081581A9 WO2001081581A9 (fr) | 2003-01-03 |
Family
ID=27393973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/012865 WO2001081581A2 (fr) | 2000-04-21 | 2001-04-20 | Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1278854A2 (fr) |
JP (1) | JP2004520803A (fr) |
AU (1) | AU2001255524A1 (fr) |
CA (1) | CA2407352A1 (fr) |
WO (1) | WO2001081581A2 (fr) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2270030E (pt) | 2000-02-28 | 2012-07-24 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
US20020086837A1 (en) * | 2000-12-21 | 2002-07-04 | Jack Gauldie | Acne vaccine |
WO2002088175A1 (fr) * | 2001-04-24 | 2002-11-07 | Otsuka Pharmaceutical Co., Ltd. | Peptide de liaison a des anticorps de la maladie de crohn et methode d'examen de ladite maladie |
WO2003040172A2 (fr) * | 2001-11-09 | 2003-05-15 | Aegera Therapeutics, Inc. | Procedes et reactifs destines aux tamis par interaction peptides-bir |
WO2003059943A2 (fr) * | 2002-01-18 | 2003-07-24 | Karo Bio Ab | Peptides specifiques a la conformation, de liaison de la proteine kinase, procedes et produits associes |
IL165364A0 (en) * | 2002-05-28 | 2006-01-15 | Omrix Biopharmaceuticals Inc | Method for obtaining anti-idiotype antibodies |
US7432061B2 (en) * | 2002-05-31 | 2008-10-07 | Biozyme, Inc. | Assays for measuring matrix metalloproteinase activities |
DE10232776A1 (de) * | 2002-07-18 | 2004-04-08 | Henkel Kgaa | Oligonukleotide zum Nachweis von Mikroorganismen |
EP1576004A2 (fr) * | 2002-12-23 | 2005-09-21 | VIB vzw | Proteine immunomodulatrice derivee des trypanosomes et ses utilisations |
TWI262192B (en) * | 2003-07-01 | 2006-09-21 | Univ Nat Taiwan | Labeling peptide for nasopharyngeal carcinoma (NPC) cells |
US7723474B2 (en) * | 2003-10-21 | 2010-05-25 | The Regents Of The University Of California | Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
WO2005047313A1 (fr) * | 2003-11-14 | 2005-05-26 | Peptide Door Co., Ltd. | Peptide ou proteine apte a fixer le lipide a et le lps, adn codant ledit peptide ou ladite proteine et utilisation dudit peptide ou de ladite proteine, adsorbant de lps ou agent de neutralisation de poison de lps |
AU2005221729B2 (en) * | 2004-03-15 | 2009-09-24 | Tissugen Pty Ltd | Infectious aetiology of prostatic disease and methods to identify causative agents |
CA2559390A1 (fr) * | 2004-03-15 | 2005-09-22 | Tissugen Pty Ltd | Etiologie infectieuse de maladie prostatique et procede d'identification d'agents etiologiques |
GB0409748D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Lactoferrin cleavage |
DE602004026284D1 (de) * | 2004-07-01 | 2010-05-12 | Biomay Ag | Hausstaubmilbenallergen |
US7501486B2 (en) | 2004-09-07 | 2009-03-10 | Burnham Institute For Medical Research | Peptides that selectively home to heart vasculature and related conjugates and methods |
CN102558334B (zh) * | 2004-09-07 | 2016-08-03 | 伯纳姆研究院 | 选择性锚定到心脏脉管系统上的肽和相关结合物和方法 |
EP1853289A4 (fr) * | 2005-01-31 | 2008-04-09 | Vaxinnate Corp | Nouveaux ligands de polypeptides destines a un recepteur de type toll 2 (tlr2) |
CA2603140A1 (fr) * | 2005-03-22 | 2006-09-28 | Novozymes A/S | Utilisation de polypeptides bacillus licheniformis dans les aliments pour animaux |
EP1907534B2 (fr) * | 2005-07-12 | 2024-04-10 | Micreos B.V. | Bacteriophage et utilisations |
US7592009B2 (en) * | 2006-10-10 | 2009-09-22 | Ecole Polytechnique Federale De Lausanne (Epfl) | Polypeptide ligands for targeting cartilage and methods of use thereof |
DE602006012515D1 (de) * | 2006-12-15 | 2010-04-08 | Giuseppe Campiani | Neuartige mit Taxan verwandte Peptide und deren Verwendung |
CA2715396A1 (fr) * | 2008-02-19 | 2009-08-27 | James J. Hogan | Compositions et procedes pour la detection d'acide nucleique de propionibacterium acnes |
WO2009120993A2 (fr) * | 2008-03-28 | 2009-10-01 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Analogues synthétiques du domaine juxtamembranaire de l'igf1r et leurs utilisations |
FR2937322B1 (fr) | 2008-10-22 | 2013-02-22 | Vect Horus | Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues |
US9340769B2 (en) * | 2008-12-05 | 2016-05-17 | The Regents Of The University Of California | Methods and compositions for treating P. acnes |
CN104127879B (zh) | 2008-12-05 | 2017-05-10 | 阿布拉西斯生物科学有限责任公司 | 结合SPARC的scFv |
FR2945125B1 (fr) * | 2009-05-04 | 2013-07-19 | Ingen Biosciences | Methode de diagnostic des infections a propionibacterium acnes |
PL2248533T3 (pl) * | 2009-05-05 | 2014-04-30 | Univ Freiburg | Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia |
FR2959229B1 (fr) * | 2010-04-21 | 2013-01-18 | Vect Horus | Derives peptidiques, leur preparation et leurs utilisations |
SG185487A1 (en) * | 2010-05-11 | 2012-12-28 | Aveo Pharmaceuticals Inc | Anti-fgfr2 antibodies |
AU2011259204B2 (en) | 2010-05-27 | 2015-05-21 | Kenichiro Hasumi | Antigen peptide and use thereof |
EP3692999A1 (fr) | 2012-03-17 | 2020-08-12 | The Regents of the University of California | Diagnostic et traitements personnalisés rapides de l'acné |
US10295547B2 (en) * | 2013-03-14 | 2019-05-21 | University Of Florida Research Foundation, Incorporated | Use and treatment of di-amino acid repeat-containing proteins associated with ALS |
WO2015138494A1 (fr) | 2014-03-10 | 2015-09-17 | Georges Belfort | Peptides anti-microbiens et procédé de conception de nouveaux peptides anti-microbiens |
CN106661543A (zh) | 2014-06-17 | 2017-05-10 | Xycrobe治疗公司 | 经遗传修饰的细菌和用于细菌的遗传修饰的方法 |
PL3356390T3 (pl) | 2015-09-28 | 2021-07-05 | The University Of North Carolina At Chapel Hill | Sposoby i kompozycje dla wektorów wirusowych unikających przeciwciał |
WO2017141248A1 (fr) * | 2016-02-17 | 2017-08-24 | Pepticom Ltd | Agonistes et antagonistes peptidiques de l'activation de tlr4 |
US11504404B2 (en) | 2016-02-24 | 2022-11-22 | Crown Laboratories, Inc. | Skin probiotic formulation |
JP2019514885A (ja) | 2016-04-21 | 2019-06-06 | ネイキッド バイオーム,インク. | 皮膚障害の処置のための組成物および方法 |
CN106167820A (zh) * | 2016-05-19 | 2016-11-30 | 胤安国际(辽宁)基因科技股份有限公司 | 鉴定或辅助鉴定痤疮丙酸杆菌的专用引物及其应用 |
JP7350337B2 (ja) | 2017-09-26 | 2023-09-26 | ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. | 神経障害の処置においてranタンパク質レベルを低下させるためのメトホルミンおよびそのアナログの使用 |
US12091435B2 (en) | 2018-04-03 | 2024-09-17 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
JP7406677B2 (ja) | 2018-04-03 | 2023-12-28 | ギンコ バイオワークス インコーポレイテッド | 抗体を回避するウイルスベクター |
US20210401976A1 (en) * | 2018-11-12 | 2021-12-30 | Imcyse Sa | Immunogenic peptides with improved oxidoreductase motifs |
JP2022507968A (ja) * | 2018-11-26 | 2022-01-18 | ノース カロライナ ステイト ユニヴァーシティ | 宿主細胞タンパク質の捕捉のためのペプチドリガンド |
JP7378839B2 (ja) * | 2018-12-26 | 2023-11-14 | スキンメドカンパニーリミテッド | アセチルコリン受容体阻害ペプチド及びその用途 |
WO2020191300A1 (fr) | 2019-03-21 | 2020-09-24 | Stridebio, Inc. | Vecteurs viraux adéno-associés recombinants |
TW202128736A (zh) | 2019-10-17 | 2021-08-01 | 美商史崔德生物公司 | 用於治療c型尼曼—匹克病之腺相關病毒載體 |
US20230048338A1 (en) * | 2019-12-20 | 2023-02-16 | PYC Therapeutics Limited | Novel cellular delivery methods |
KR20230005127A (ko) | 2020-02-21 | 2023-01-09 | 오리짐 바이오테크놀로지 게엠베하 | 프로피오니박테리움 아크네스 예방적 및 치료적 면역 처치 |
WO2021231988A2 (fr) * | 2020-05-15 | 2021-11-18 | University Of Southern California | Peptides dérivés de mitochondries et leurs analogues destinés à être utilisés en tant que thérapie pour des maladies liées à l'âge y compris le cancer |
EP4167937A1 (fr) | 2020-06-23 | 2023-04-26 | Crown Laboratories, Inc. | Formulations cutanées probiotiques |
AR123288A1 (es) | 2020-08-19 | 2022-11-16 | Stridebio Inc | Vectores de virus adenoasociados para el tratamiento del síndrome de rett |
KR20230083100A (ko) * | 2021-12-02 | 2023-06-09 | 삼성전자주식회사 | 폴리펩티드, 이를 포함하는 포토레지스트 조성물 및 이를 이용한 패턴 형성 방법 |
WO2024145574A2 (fr) * | 2022-12-30 | 2024-07-04 | Cedars-Sinai Medical Center | Vaccins ciblant la hyaluronidase c. acnes pour la prophylaxie et le traitement de l'acné vulgaire |
-
2001
- 2001-04-20 EP EP01928693A patent/EP1278854A2/fr not_active Withdrawn
- 2001-04-20 WO PCT/US2001/012865 patent/WO2001081581A2/fr not_active Application Discontinuation
- 2001-04-20 JP JP2001578652A patent/JP2004520803A/ja not_active Withdrawn
- 2001-04-20 CA CA002407352A patent/CA2407352A1/fr not_active Abandoned
- 2001-04-20 AU AU2001255524A patent/AU2001255524A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
CORIXA CORPORATION - POWERING THE IMMUNE SYSTEM, XP002180961, Retrieved from the Internet <URL:http://www.corixa.com/default.asp?pid=release_detail&year=2001&ID=9> [retrieved on 20011018] * |
DATABASE EMBL 16 February 1998 (1998-02-16), NATIONAL CANCER INSTITUTE: "nj43f09.s1 NCI_CGAP_Pr9 Homo sapiens cDNA clone", XP002281294, accession no. ACCESSION NUMBER AA809595 * |
MISKIN J E ET AL: "PROPIONIBACTERIUM ACNES, A RESIDENT OF LIPID-RICH HUMAN SKIN, PRODUCES A 33 KDA EXTRACELLULAR LIPASE ENCODED BY GEHA", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 143, no. 5, 1997, pages 1745 - 1755, XP000952640, ISSN: 1350-0872 * |
STEINER B ET AL: "CLONING AND SEQUENCING OF THE HYALURONATE LYASE GENE FROM PROPIONIBACTERIUM ACNES", CANADIAN JOURNAL OF MICROBIOLOGY, OTTAWA, CA, vol. 43, no. 4, 1997, pages 315 - 321, XP000952641, ISSN: 0008-4166 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001255524A1 (en) | 2001-11-07 |
EP1278854A2 (fr) | 2003-01-29 |
CA2407352A1 (fr) | 2001-11-01 |
JP2004520803A (ja) | 2004-07-15 |
WO2001081581A9 (fr) | 2003-01-03 |
WO2001081581A2 (fr) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001081581A3 (fr) | Compositions et procedes pour la therapie et le diagnostic de l'acne vulgaire | |
WO2001092581A8 (fr) | Compositions et methodes permettant le traitement et le diagnostic du cancer de l'ovaire | |
WO2001072295A3 (fr) | Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon | |
WO2001096388A8 (fr) | Compositions et procedes servant a traiter et a diagnostiquer le cancer du colon | |
WO2001000828A3 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du poumon | |
WO2002060317A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du pancreas | |
WO2001096390A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du colon | |
WO2001034802A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer de la prostate | |
WO2000004149A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
WO2000060077A3 (fr) | Composes utilises dans la therapie et le diagnostic du cancer du poumon et methodes d'utilisation | |
WO2001051633A3 (fr) | Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate | |
WO2001073032A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
WO2002004514A3 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du poumon | |
WO2001079286A3 (fr) | Compositions et procedes de traitement et de diagnostic du cancer du sein | |
WO2002074237A8 (fr) | Compositions et procedes de therapie et de diagnostic du cancer du rein | |
WO2002092001A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer du poumon | |
WO2000037643A3 (fr) | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation | |
WO2002012328A8 (fr) | Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon | |
WO2003037267A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer des poumons | |
WO2002058534A8 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du colon | |
WO2001077168A3 (fr) | Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon | |
WO2002039885A3 (fr) | Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire | |
WO2001057207A3 (fr) | Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire | |
WO2002012280A3 (fr) | Compositions et procedes pour le diagnostic et le traitement du cancer du colon | |
WO2001090152A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du sein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 578652 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2407352 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001928693 Country of ref document: EP |
|
COP | Corrected version of pamphlet |
Free format text: TABLE 2, DESCRIPTION, ADDED (10 PAGES) |
|
WWP | Wipo information: published in national office |
Ref document number: 2001928693 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001928693 Country of ref document: EP |